APA

Jhaveri K., Chandarlapaty S., Lake D., Gilewski T., Robson M., Goldfarb S., Drullinsky P., Sugarman S., Wasserheit-Leiblich C., Fasano J., Moynahan M. E., D'Andrea G., Lim K., Reddington L., Haque S., Patil S., Bauman L., Vukovic V., El-Hariry I., Hudis C. & Modi S. (20141231). A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. : Clinical breast cancer.

Chicago

Jhaveri Komal, Chandarlapaty Sarat, Lake Diana, Gilewski Teresa, Robson Mark, Goldfarb Shari, Drullinsky Pamela, Sugarman Steven, Wasserheit-Leiblich Carolyn, Fasano Julie, Moynahan Mary Ellen, D'Andrea Gabriella, Lim Kristina, Reddington Laura, Haque Sofia, Patil Sujata, Bauman Lynne, Vukovic Vojo, El-Hariry Iman, Hudis Clifford and Modi Shanu. 20141231. A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. : Clinical breast cancer.

Harvard

Jhaveri K., Chandarlapaty S., Lake D., Gilewski T., Robson M., Goldfarb S., Drullinsky P., Sugarman S., Wasserheit-Leiblich C., Fasano J., Moynahan M. E., D'Andrea G., Lim K., Reddington L., Haque S., Patil S., Bauman L., Vukovic V., El-Hariry I., Hudis C. and Modi S. (20141231). A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. : Clinical breast cancer.

MLA

Jhaveri Komal, Chandarlapaty Sarat, Lake Diana, Gilewski Teresa, Robson Mark, Goldfarb Shari, Drullinsky Pamela, Sugarman Steven, Wasserheit-Leiblich Carolyn, Fasano Julie, Moynahan Mary Ellen, D'Andrea Gabriella, Lim Kristina, Reddington Laura, Haque Sofia, Patil Sujata, Bauman Lynne, Vukovic Vojo, El-Hariry Iman, Hudis Clifford and Modi Shanu. A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. : Clinical breast cancer. 20141231.